New York (February 13, 2024) —Weill Cornell Medicine today announced that Sumit Gupta, Ph.D., a physician-scientist whose research focuses on vulnerable subpopulations of childhood cancer, will be recognized at the 8th Gail and Ira Awards in the Division of Child Health Research.・It was announced that he had won the Dolkia Award.
Dr. Sumit Gupta
The Dolkier Prize recognizes young pediatricians whose research is expected to make a significant contribution to improving the health of children and adolescents. Dr. Gupta is an Associate Professor in the Department of Pediatrics and the Institute for Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, and Associate Scientist and Head of the Leukemia and Lymphoma Unit at the University of Toronto Hospital. He is from SickKids in Toronto, Ontario. He is recognized for his research using health data to answer important clinical and health policy questions affecting children living with cancer locally and around the world.
Dr. Gupta's most recent research includes a U.S. Department of Defense-funded study of the late effects of cancer treatment in adolescents and young adults, and a Canadian government-funded childhood cancer early detection program in Kenya and Cameroon. Includes design and evaluation. Institute for Health Research (CIHR).
Dr. Gupta received the award, which includes an unrestricted honorarium, and presented his latest research at a ceremony on February 13th. Dr. Carola Vinueza, a renowned immunologist and researcher at the Francis Crick Institute in London, UK, will present a lecture on child health by Gail and Ira Dolkier, whose research has contributed to significant advances in child health. and focused on discovery.
Dr. Carola Vinueza
The Drukier Award and Lecture was established in December 2014 as part of a $25 million gift to Weill Cornell Medicine from Dr. Gail Drukier and Weill Cornell Medicine Board member Ira Drukier. This gift created the Gail and Ira Dolkier Institute for Child Health. A major interdisciplinary research institute dedicated to accelerating research into the root causes of devastating childhood diseases.
“Dr. said Dr. Robert A. Harrington, Dean and Suzanne Weiss Dean and Dean of Cornell Medicine. . “We are grateful to the Dolkee family for establishing this prestigious award and for their continued support of this important field of medicine, and we are pleased to recognize Dr. Gupta with this year’s award.”
“We are honored to shine a spotlight on outstanding physicians and scientists like Dr. Gupta who are dedicated to improving the health of children,” said Dr. Gail Dolkier and Fellow Director Dr. Ira Dolkier. ” he said. “Dr. Gupta's research, which addresses some of the challenges faced by pediatric cancer patients, offers hope to pediatric cancer patients and their families, and he has a bright future ahead of him in child health research.” Masu.”
“Dr. said Dr. Virginia Pascual, Director of Menschel Dorquier. Professor of Pediatrics, Weill Cornell Medical College. “His research has great potential to improve access to treatment, treatment outcomes, and quality of life for many young people, and the Dolkier Institute recognizes his tireless efforts to advance these goals. I’m happy to be able to congratulate you.”
Dr. Sumit Gupta
In her research, Dr. Gupta analyzes medical data to answer important questions about the challenges faced by children with cancer. For example, he led an investigation into the impact of stopping an essential chemotherapy for acute lymphoblastic leukemia (ALL) called asparaginase by analyzing clinical trial data from North America, Australia, and New Zealand. At the time, the drug was often discontinued due to allergic reactions, and supply issues often prevented replacement drugs from being available. The study found that children who received alternative drugs achieved similar outcomes compared to children who received standard treatment. However, survival rates were low for those who did not receive the full dose of either drug. This finding led to changes in treatment strategies and further support for strengthening supply chain policies.
Dr. Gupta's Global Health Research showed that childhood cancer treatment in Ghana is cost-effective. This insight provides local advocates with key evidence that led Ghana's Ministry of Health to cover childhood cancer under the country's universal healthcare system, improving access to life-saving treatment for more young patients. provided. Dr. Gupta's research also shows that survivors of childhood, adolescent, and young adult cancers in Ontario are not at increased risk of infection or serious complications from COVID-19. The findings provided essential guidance for risk counseling and reduced the anxiety experienced by patients and their families during cancer treatment. Pandemic.
“It is a great honor to receive the Dolkier Award from Weill Cornell Medicine,” said Dr. Gupta. “It is also a great opportunity to highlight the incredible progress made in childhood cancer research both locally and globally, and to recognize how much work remains to be done.”
Dr. Gupta received his medical degree from the University of Toronto in 2005 and his Ph.D. In 2014 he received his PhD in Clinical Epidemiology. From 2010, after completing his pediatric training and subspecialty training in pediatric hematology/oncology at SickKids and earning his Ph. Appointed head of epidemiology. In 2023 he will be in charge of the leukemia and lymphoma section. Also in 2023 he was awarded the Garron Family Chair in Childhood Cancer Research at SickKids.
Dr. Gupta is a member of the American Society of Clinical Oncology and the American Society of Hematology. He serves on several committees, including vice chair of his ALL committee in the Pediatric Oncology Group and working group leader for the National Childhood Cancer Registry Initiative at the National Cancer Institute.
Dr. Gupta has received the 2022 Canadian Cancer Society William E. Rawls Award for his contributions as an early career researcher, as well as the Alvin Zipursky Award from SickKids Pediatrics for exemplary teaching and research and development. He has received several prestigious awards, including awards. Initiatives in the fellowship program.
Dr. Carola Vinueza
Dr. Vinueza is a Wolfson Fellow of the Royal Society and Deputy Research Director and Principal Group Leader at the Francis Crick Institute. Her research has significantly advanced our understanding of the immune system and identified novel genes that promote the development and progression of autoimmune diseases such as lupus.
In 2023, she received the Lupus Insight Award from the Lupus Research Alliance and the Johann Anton Merck Award from Merck KGaA for discovering that a rare genetic mutation in the viral RNA sensor TLR7 causes lupus in some patients. Her findings provided important insights into the disease mechanisms of lupus and provided the rationale for the use of novel therapies targeting TLR7 in lupus.
Through genetic research, Dr Vinueza also recently helped free an Australian woman who was wrongly convicted of suffocating her children. After sequencing the woman's and child's genomes, Dr. Vinueza discovered that two of the children had inherited a new genetic mutation in their genes. calm 2 Testimony from mothers, which can cause cardiac arrest and sudden death, proves that women are not responsible for their deaths. She was released in June 2023 after serving a 20-year sentence and was recently acquitted.
Dr. Vinueza received his medical degree from the Autonoma University of Madrid and completed his professional medical training and Ph.D. in the United Kingdom. He holds a degree in immunology from the University of Birmingham, London. Following his doctoral training in immunogenetics at the Australian National University, he progressed from group leader to professor to department head. From 2014 until 2021, she directed the Center for Personalized Immunology, a National Health and Medical Research Council Center of Excellence based in Australia. She has been elected a Fellow of the Australian Academy of Science (FAA), a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS), a Fellow of the Academy of Medical Sciences (FMedSci) and a Fellow of the Royal Society (FRS).
Weill Cornell Medicine
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery, and educating future physicians in New York City and around the world. Weill Cornell Medicine physicians and scientists, faculty members of Weill Cornell Medical College, Weill Cornell Medical College, and Weill Cornell Physician Organization, provide world-class clinical care and cutting-edge research that connects patients with the latest treatments. engaged. Innovation and prevention strategies. Located in the heart of the Upper East Side scientific corridor, Weill Cornell Medicine's strong network of collaborators extends to its parent university, Cornell University. In Qatar, Weill Cornell Medicine Qatar offers medical degrees from Cornell University. We will also participate in programs in Tanzania, Haiti, Brazil, Austria, and Turkey. Weill Cornell Medical School faculty members include New York Presbyterian/Weill Cornell Medical Center, New York Presbyterian Westchester Behavioral Health Center, New York Presbyterian Lower Manhattan Hospital, New York Presbyterian Queens Hospital, and New York Presbyterian Brooklyn Methodist Hospital. Provides exemplary patient care. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.
